ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1335

Effectiveness of Longstanding Exercise Therapy versus Usual Care in People with Rheumatoid Arthritis and Severe Functional Limitations: A Randomized Controlled Trial (L-EXTRA)

Max Teuwen1, Salima van Weely1, Thea Vliet Vlieland2, Manja van Wissen1, Wilfred Peter1, Alfons den Broeder3, Dirkjan van Schaardenburg4, Wilbert van den Hout1, Cornelia van den Ende3 and Maaike gademan1, 1Leiden University Medical Center, Leiden, Netherlands, 2Leids University Medical Center, Leiden, Netherlands, 3Sint Maartenskliniek, Nijmegen, Netherlands, 4Reade, Amsterdam, Netherlands

Meeting: ACR Convergence 2023

Keywords: Comorbidity, exercise, physical therapy, Randomized Trial, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (1308–1344) RA – Treatments Poster II

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Supervised exercise therapy is an effective and safe treatment option for people with rheumatoid arthritis (RA). However, most studies involve interventions of relatively short duration (≤12 weeks) or in patients with stable disease and a favorable health status. Patients with persistent disease activity, irreversible joint damage, multiple joint replacements and/or severe comorbidities are underrepresented in research, although in particular patients in this subgroup might be in need of exercise therapy, most likely longstanding. However, studies on longstanding exercise interventions in this subgroup are lacking. Therefore, this study aimed to evaluate the effectiveness of longstanding personalized, supervised exercise therapy compared with usual care in people with RA and severe functional limitations.

Methods: Adults with RA and severe limitations in basic activities of daily living were randomized 1:1 to longstanding ( >52 weeks) personalized, supervised exercise therapy or usual care. The intervention consisted of exercise therapy tailored to individual goals, combined with self-management support to increase physical activity and fitness levels, and was delivered by specifically trained, primary care physical/exercise therapists. The primary endpoint was the change in the Patient-Specific Complaint (PSC (0-10)) at 52 weeks. Secondary endpoints included the Health Assessment Questionnaire-Disability Index (HAQ-DI), Rheumatoid Arthritis Quality of Life questionnaire Patient (RAQoL), 6-minute walk test (6MWT), Patient Reported Outcome Measurement Information System-Physical Function-10 (PROMIS-PF-10) and the Short Form-36 (SF-36). Results are reported from the 52-week rater-blind treatment period using analysis of covariance, expressed as mean difference between change scores with the 95% confidence interval.

Results: 215 people (90% female, age 58.8 (SD; 12.9) years) with RA and severe functional limitations were randomized. At 52 weeks n=104 (intervention) and n=98 (usual care) participants were included in the intention-to-treat analyses. The improvement in the primary outcome (PCS) was statistically significantly greater in the intervention group vs usual care difference in change score between groups (mean [95% CI] -1.7 [-2.4 – 1.0]) at week 52. Except for the PROMIS-PF-10 and SF-36, all secondary outcomes showed statistically significantly greater improvements in the intervention group vs usual care group at week 52 (HAQ-DI 0.17 [0.05 – 0.29], RAQoL 1.97 [0.62 – 3.32], 6MWT 56 meter [38 – 75]) indicating consistent improvements across domains, with between-group effect sizes ranging from 0.4 to 0.9. No intervention-related (serious) adverse events were reported.

Conclusion: Longstanding, personalized, supervised exercise therapy was more effective than usual care after 52 weeks of treatment in people with RA and severe functional limitations. Improvements were consistently observed across domains.

Supporting image 1


Disclosures: M. Teuwen: None; S. van Weely: None; T. Vliet Vlieland: None; M. van Wissen: None; W. Peter: None; A. den Broeder: None; D. van Schaardenburg: None; W. van den Hout: None; C. van den Ende: None; M. gademan: None.

To cite this abstract in AMA style:

Teuwen M, van Weely S, Vliet Vlieland T, van Wissen M, Peter W, den Broeder A, van Schaardenburg D, van den Hout W, van den Ende C, gademan M. Effectiveness of Longstanding Exercise Therapy versus Usual Care in People with Rheumatoid Arthritis and Severe Functional Limitations: A Randomized Controlled Trial (L-EXTRA) [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/effectiveness-of-longstanding-exercise-therapy-versus-usual-care-in-people-with-rheumatoid-arthritis-and-severe-functional-limitations-a-randomized-controlled-trial-l-extra/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/effectiveness-of-longstanding-exercise-therapy-versus-usual-care-in-people-with-rheumatoid-arthritis-and-severe-functional-limitations-a-randomized-controlled-trial-l-extra/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology